In 2011, Thirunavukarasu et al. (25) reported that preoperative serum CEA level was an independent prognostic biomarker of colon cancer, and prognosis was worse in high CEA patients with a lower stage compared with low CEA patients with a higher stage. This evidence concerns the gene CEACAM5 and colonic neoplasm.